๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

TAF

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 6 trials in our China, USA and India registers that name TAF as an intervention. Synced 25 Sep 2026
6Trials tracked
0Recruiting now
5Lead sponsors
3Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

TAF is named as a drug or biological intervention in 6 clinical trials in our China, USA and India trial registers, none of which are currently recruiting. Lead sponsors include The Third Affiliated Hospital of Guangzhou Medical University (2), Gilead Sciences (1) and Xi'an Xintong Pharmaceutical Research Co.,Ltd. (1). Registered phases: Phase 4, Phase 2, Phase 2/3 and Phase EARLY_PHASE1. Conditions studied include Chronic Hepatitis B; HIV Infection; HIV.

01

Clinical trials of TAF

6 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT07553767 Efficacy and Safety of Pegylated Interferon Alpha-2ฮฒ in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection (ClinicalTrials.gov ↗)
Hepatocellular Carcinoma, HEPATITIS B CHRONIC, Hepatitis B Chronic Infection
Phase EARLY_PHASE1 Not yet open Ningbo No.2 Hospital China
NCT06830668 Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation (ClinicalTrials.gov ↗)
HIV Infection, HIV
Phase 4 Not yet open National Center for AIDS/STD Control and Prevention, China CDC China
NCT07542951 TAF vs TDF During the Pregancy (ClinicalTrials.gov ↗)
Hepatitis B Virus Infection; Pregnant Women
Phase 4 By invitation The Third Affiliated Hospital of Guangzhou Medical University China
NCT07668934 TAF in Early/Middle Pregnancy With CHB (ClinicalTrials.gov ↗)
Hepatitis B Infection, Pregnant Women, Early Pregnancy
Phase 4 By invitation The Third Affiliated Hospital of Guangzhou Medical University China
NCT07203118 A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B (ClinicalTrials.gov ↗)
Chronic Hepatitis B
Phase 2/3 Active, closed Xi'an Xintong Pharmaceutical Research Co.,Ltd. China
NCT02932150 Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
Chronic Hepatitis B
Phase 2 Active, closed Gilead Sciences USA, India

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

10 conditions
Condition (as registered)Trials
Chronic Hepatitis B2
HIV Infection1
HIV1
Hepatitis B Infection1
Pregnant Women1
Early Pregnancy1
Hepatitis B Virus Infection; Pregnant Women1
Hepatocellular Carcinoma1
HEPATITIS B CHRONIC1
Hepatitis B Chronic Infection1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
The Third Affiliated Hospital of Guangzhou Medical University2
Gilead Sciences1
Xi'an Xintong Pharmaceutical Research Co.,Ltd.1
National Center for AIDS/STD Control and Prevention, China CDC1
Ningbo No.2 Hospital1
04

Trials by country register

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how TAF works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists TAF (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.